P. Clouet

A phase II study

Philippe Rougier, Antoine Adenis, Michel Ducreux et al. · European Journal of Cancer · 2000 · 752 citations

Public Health, Biostatistics, Experimental Design +4

Phase II randomised trial comparing docetaxel given every 3 weeks with weekly schedule as second-line therapy in patients with advanced non-small-cell lung cancer (NSCLC)

R. Gervais, A Ducoloné, Jean-Luc Breton et al. · Annals of Oncology · 2004 · 117 citations

Medicine, Oncology, Pharmacotherapy +13

Imaging of thoracic and lumbar spinal extradural arachnoid cysts: report of two cases

A Rimmelin, P. Clouet, S Salatino et al. · Neuroradiology · 1997 · 72 citations

Medicine, Neurosurgery, Radiology +11

Randomised, multicentre phase II study assessing two doses of docetaxel (75 or 100 mg/m2) as second-line monotherapy fornon-small-cell lung cancer

Élisabeth Quoix, B Lebeau, A Depierre et al. · Annals of Oncology · 2003 · 43 citations

Medicine, Oncology, Pharmacology +12

Sequential two-line strategy for stage IV non-small-cell lung cancer: docetaxel–cisplatin versus vinorelbine–cisplatin followed by cross-over to single-agent docetaxel or vinorelbine at progression: final results of a randomised phase II study

Jean‐Yves Douillard, R. Gervais, G Dabouis et al. · Annals of Oncology · 2004 · 37 citations

Medicine, Oncology, Pharmacology +17